Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


49th week of 2015 patent applcation highlights part 8
Patent application numberTitlePublished
20150342807METHOD AND APPARATUS FOR SETTING OR MODIFYING PROGRAMMABLE PARAMETER IN POWER DRIVEN WHEELCHAIR - A method and apparatus for setting or modifying a programmable operating parameter associated with a power driven wheelchair is provided. In one embodiment, the method includes: a) operating a user interface device associated with a power driven wheelchair in a programming mode, b) selecting a programmable operating parameter associated with operation of the power driven wheelchair using the user interface device, c) selecting a value for the programmable operating parameter using the user interface device, and d) saving the selected value for the programmable operating parameter in a portion of a storage device associated with the power driven wheelchair using the user interface device. A method and apparatus for selecting one or more programmable parameter sets from a portable storage medium and saving the selected sets to a local storage device associated with a power driven wheelchair and vice versa is also provided.2015-12-03
20150342808U-turner - A method and apparatus for turning a patient onto their side without having to place anything under the patient's torso in order to turn the patient are provided.2015-12-03
20150342809TRANSMISSION FOR AN ADJUSTABLE-HEIGHT PLATFORM AND METHOD FOR CHANGING A HEIGHT OF A PLATFORM - A transmission for an adjustable-height platform includes at least one drive shaft, at least one output shaft, at least one first gear wheel configured to transmit a rotational movement of the drive shaft to the output shaft, and at least one second gear wheel configured to drive a hollow second output shaft. The at least one first gear wheel is formed from or includes at least portions formed from plastic.2015-12-03
20150342810Lifting Sling Device - Disclosed is a lifting sling device. Fabric of a sling is made of a biodegradable non-woven polymeric material. Using the lifting sling device according to the present invention can not only avoid cross-infection due to use among different patients, but also can avoid a negative influence on the environment after the lifting sling device is discarded because the lifting sling device is biodegradable.2015-12-03
20150342811Manual Lifting Sling Apparatus - Disclosed is a manual lifting sling apparatus (2015-12-03
20150342812GRAVITY DISPENSING BIN SYSTEM - A device for storing, transporting and dispensing medical items is provided, wherein the device comprises a multiplicity of compartments with an upper facing space and lower facing space.2015-12-03
20150342813CARRIAGE FOR A SURGICAL BOOT OF A HIP DISTRACTOR - A carriage for a limb support includes a space for receiving a longitudinal member of a patient support apparatus, a plurality of rollers configured to engage the longitudinal member and a locking mechanism. The plurality of rollers is configured to maintain alignment of the carriage during movement of the carriage along the longitudinal member. The carriage also includes an elastomeric member that resists rotation to prevent unwanted motion of the carriage. The locking mechanism is configured to secure the carriage to the longitudinal member at any of an infinite number of positions along the length of the longitudinal member, the locking mechanism being lockable with a single action.2015-12-03
20150342814APPARATUS FOR POSITIONING A LEG OF SUPINE PATIENTS FOR SERVICING - A leg positioning apparatus for improved access to a leg in a supine position includes a base that engages a surface being laid on by a patient. The apparatus further includes a first tube having a first hole on the upper portion of the base. The apparatus further includes a leg holder that engages a leg of the patient. The apparatus further includes a second tube having a second hole on the lower portion of the leg holder. The first and second tubes telescopingly engaging each other to couple the base to the leg holder. The apparatus further includes a pin that engages the first and second holes to couple the first and second tubes to each other.2015-12-03
20150342815WALL MOUNT MASSAGER - The present invention relates to massage assembly structured for mounting on a vertical supporting surface during a massaging procedure. The massage assembly includes an elongated housing mounted on the supporting surface in a substantially vertical orientation. A contact assembly is movably disposed on the housing and is operative to apply a massaging pressure to predetermined body portions of the user. A sensor assembly is disposed and structured to determine at least one area of engagement between the housing and the user's body. A drive assembly is connected in driving relation to the contact assembly. The sensor assembly is connected to the drive assembly and is operative to determine at least one area of application of the contact assembly on the predetermined body portion.2015-12-03
20150342816Vibration Apparatus - A traction bed includes (a) a frame upon which an individual is supportable, (b) a first single-sided lever arm pivotably coupled to the frame at a location proximate both a first end of the frame and a first side of the frame, wherein the first single-sided lever arm is configured to be coupled to an arm of an individual, (c) a second single-sided lever arm pivotably coupled to the frame at a location proximate both a second end of the frame and the first side of the frame, wherein the second single-sided lever arm is configured to be coupled to a leg of an individual, and (d) a control system operable to direct a force onto each of the single-sided lever arms to pivot the single-sided lever arms relative to the frame, wherein the force directed to the first single-sided lever arm is separately variable from the force directed to the second single-sided lever arm.2015-12-03
20150342817LOWER LIMBS REHABILITATION TRAINING ROBOT - A lower limb rehabilitation training robot is provided, which includes a bedstead support and a rising bedstead arranged on the bedstead support, and further includes a linear motion device, a push rod device, a bionic leg arranged at one end of a surface of the rising bedstead and hinged to the rising bedstead, and a bed board configured to support a patient and arranged at another end of the rising bedstead. The linear motion device is arranged between the bedstead support and the rising bedstead, is configured to allow the rising bedstead to slide along the bedstead support, and has one lateral surface connected to the bedstead support and another lateral surface hinged to the rising bedstead. The push rod device is configured to drive the rising bedstead to rotate around a hinge point where the rising bedstead is hinged to the linear motion device.2015-12-03
20150342818DRIVING DEVICE AND DRIVING METHOD - A driving device includes a wearable mechanism that is worn on a wearing part, an actuator that drives the wearable mechanism, and first and second force sensors that are provided on the wearable mechanism and detect a force. The first and second force sensors are provided at positions at which a first detected value obtained from the first force sensor and a second detected value obtained from the second force sensor are changed in response to a motion of the wearing part. When a difference between the first and second detected values is less than a pre-decided first threshold value and the first or second detected value is greater than a pre-decided second threshold value, the actuator drives the wearable mechanism so that the second detected value is constant.2015-12-03
20150342819WALKING TRAINING SYSTEM AND WALKING TRAINING METHOD OF THE SAME - A walking training system includes a walking assistance apparatus that is mounted on a leg portion of a user, and assists the user's walking, first pulling means for pulling at least one of the walking assistance apparatus and the leg portion of the user to a front side; and second pulling means for pulling at least one of the walking assistance apparatus and the leg portion of the user to a rear side. A pulling point of the walking assistance apparatus and/or the leg portion of the user, which is pulled by the first and second pulling means is provided to be movable around the leg portion of the user.2015-12-03
20150342820WALK TRAINING APPARATUS AND WALK TRAINING METHOD THEREOF - A walk training apparatus includes a walking assist device, a first tensile portion, and a second tensile portion. The walking assist device is configured to be attached to a leg of a user so as to assist the user in walking. The first tensile portion pulls at least one of the walking assist device and the leg of the user toward a vertically upper side and toward a front side. The second tensile portion pulls at least one of the walking assist device and the leg of the user toward the vertically upper side and toward a rear side.2015-12-03
20150342821VAULTING MONO-CRUTCH - In embodiments, a mobility system can include a support member configured to engage a posterior region of a user and a mast attachable to the support member in proximity of a hip joint of the user. The mast is structured to extend above the user's waist along one side of the user. The mast can be at least partially lifted from the ground and repositioned when a weight of the user is shifted to a mobile leg of the user. The mast can also receive a force exerted on the support member by the user, such that the weight of the user is supported from an attachment site of the mast and the support member (i.e., from an attachment point near the user's hip joint) when the weight of the user is shifted away from the mobile leg of the user.2015-12-03
20150342822WALKING REHABILITATION ASSISTANCE DEVICES - Walking rehabilitation assistance devices that facilitate mobility in users that are rehabilitating for walking. The walking rehabilitation assistance device is essentially a support frame with wheels and a seat for the user that is attached to a flexible strap. The user straddles the seat, which in turn is attached to a tensioning device, allowing the seat to be raised so as to transfer some or all of the user's weight from the user's legs to the walking rehabilitation assistance device. In some examples, the walking rehabilitation assistance device includes a rigid seat receiver that is connected to the flexible strap, to enable the use of different styles of seats such as bicycle seats, and may provide enhanced stability in certain circumstances.2015-12-03
20150342823Hair and Scalp Revitalization - The instant application discloses, among other things, techniques to provide for Hair and Scalp Revitalization. In one embodiment, a person may shampoo a head of hair using lukewarm water, scrubbing the entire scalp vigorously yet gently. The person may then blot the hair with a towel until the hair reaches a wet, but not dripping, state. While the hair is wet, the person may use a brush or comb to gently detangle the strands. The person may then use a brush, which may have a cushion base and flexible teeth, to perform vigorous strokes over the entire scalp, applying pressure on areas such as the top, temple, crown, and nape of the head and neck, for instance. The pressure on the scalp may stimulate blood circulation, eliminate toxins, and maximize nutrients to improve the health of the hair and scalp and, in most cases, regenerate hair growth.2015-12-03
20150342824APPARATUS FOR TREATING PROGRESSIVE MUSCLE AND BONE LOSS - An apparatus to treat progressive bone and muscle loss by applying vibrational and radiant energy to a human body. The vibrational energy is preferably applied by a vibrational platform that transmits gentle, dynamic, repetitive vibrations to the soles of the feet. The radiant energy is preferably provided by a bed or tanning booth that emits ultraviolet radiation.2015-12-03
20150342826VIBRATING MASSAGE APPARATUS AND A BLUETOOTH HEADSET - A vibrating massage apparatus comprises a control device and at least one vibrating device. The control device comprises a waveform generator module for outputting a control signal having a waveform, and a motor drive for receiving the control signal. The at least one vibrating device comprises a housing, a vibrator and a patch. The vibrator is disposed in the housing and is electrically connected to the motor drive, wherein the motor drive controls the vibrator to vibrate in correspondence with the waveform according to the control signal. The patch has one side pasted on one surface of the housing, and the other side pasted on a skin surface.2015-12-03
20150342827VARIABLE CAPSULE-TYPE HOT-AIR BATH APPARATUS - A variable capsule-shaped hot-air bath apparatus, includes: a first hot-air bath including a first cover covering and protecting an upper part thereof, a first film heater attached to a lower part of the first cover, a first frame attached and fixed to a circumference of one side of the lower part of the first cover and formed in a U-shape, legs coupled to the lower part of one side of the first frame, and wheels coupled to lower parts of the legs; and a second hot-air bath including a second cover covering and protecting an upper part thereof, a second film heater attached to a lower part of the second cover, a second frame attached and fixed to a circumference of one side of the lower part of the second cover, rail parts mounted on and fixed to inner sides of both sides of the second frame for smooth movement.2015-12-03
20150342828METHOD FOR THE FILLING OF CONTAINERS WITH AUTOLOGOUS FRESH BLOOD COMPONENTS - A method for the filling of containers with autologous fresh blood components, comprising the following phases of: 2015-12-03
20150342829MEDICATION DISPENSING STATION - A medication dispensing station is provided. The medication dispensing station includes a support base and a cradle pivotally attached to the support base in an elevated position relative to the support base. A medication dispenser may be releasably attachable to the cradle. Therefore, a patient may easily attach the medication dispenser to the cradle, and pivot the cradle to dispense the medication.2015-12-03
20150342830PILL DISPENSING SYSTEM - A pill dispenser comprising a container operatively arranged to hold at least one pill, a cap/timer assembly rotatably secured to the container, the cap/timer assembly arranged to be set to a time interval for dispensing the at least one pill, means for alerting a user when the timer has been set to the time interval, and a dispenser housed within the container and the cap, the dispenser operatively arranged to dispense only one pill at the beginning of the time interval, and to prevent dispensing until the time interval has elapsed. The dispenser also includes an audible alert to indicate that a pill has been dispensed.2015-12-03
20150342831TWIST TOP 2000 - I Have invented a new baby bottle. That has been designed to hold two liquids inside one 8½ oz. bottle. This bottle can also discharge each liquid from the same op or nipple separately, without mixing the two sides. What I have done was taken the old conventional baby bottle, and reconstructed a new improved design. “THE TWIST TOP 2000”. This new baby bottle will not only hold and dispense two liquids. It has a new sleaker design. We have installed infant holding handles. These handles are used to equal out the bottle weight, and small enough for a infant to grab and hold at an earlier stage. Instead of making two bottles to hold each liquid, Now one bottle can do the job. This means less time to prepare and more time to be aware of your child or infant. No more digging around to find that other bottle. No more carring around that extra weight. “THE TWIST TOP 2015-12-03
20150342832LIQUID NUTRITION BOTTLE - A bottle for storing liquid nutrition and feeding liquid nutrition to an infant. The bottle includes a base portion, a neck portion for removably securing a cap or nipple, and a body portion disposed between the base portion and the neck portion. A rib protrudes from an outer surface of the bottle and is arranged for manual gripping by a user to manipulate a position of the bottle relative the infant. The outer surface of the bottle may include at least two remote and distinct outer surface areas which each define a cylindrical section of the bottle. Each surface area may be positioned for engagement by machinery during a filling operation.2015-12-03
20150342833UNIDIRECTIONAL VALVE FOR PRESSURIZED CONTAINERS - In a nipple for a baby feeding container, a valve part is disclosed, comprising a unidirectional valve formed of a pliable material and oppositely oriented such that when attached to the container a normal fluid flow through the valve is into the container while a flow from the container to the outside is normally blocked, the valve is characterized by a plurality of normally closed non intersecting slits formed in a deformable wall which blocks the flow of liquid from the container to the outside unless when the slits become temporarily distorted by the natural mouth maneuverings of a baby. The valve is especially advantageous for use in baby feeding containers of inflatable type in which the liquid content is pressurized under the pressure exerted by the stretched elastomeric walls of the container.2015-12-03
20150342834GASTROSTOMY DEVICE WITH CONTROLLED SHAPE SILICONE BALLOON - A gastrostomy device includes an elongate tube extending from a proximal end to a distal end and having a tube diameter. The elongate tube has a length that enables the elongate tube to extend from a position exterior a patient to a position interior the patient's stomach. A resealable valve is disposed within the proximal end of the elongate tube. An inflation lumen extends along the elongate tube and an inflation port is disposed near the proximal end of the elongate tube and is in fluid communication with the inflation lumen. A silicone balloon is secured relative to the distal end of the elongate tube and is in fluid communication with the inflation lumen. The silicone balloon has a distal region, a proximal region and an intervening middle region that, when inflated, stretches more than the distal region or the proximal region.2015-12-03
20150342835Enteral Feeding Pump Certification - A method of performing a certification on an enteral feeding pump based on at least one operating parameter of the pump includes communicating certification information between the pump and a certification application remote from the pump. The at least one operating parameter is compared to a specified operating metric to verify that the at least one operating parameter of the pump is within the specified operating metric.2015-12-03
20150342836Imaging Feeding Tube with Illumination Control - A feeding tube assembly having a flexible feeding tube with an imaging assembly including an illumination source configured to illuminate an ambient environment of the imaging assembly and an imaging device configured to generate and transmit imaging signals indicative of images of an alimentary canal of a subject is disclosed. The feeding tube assembly has controller in communication with the illumination source wherein the controller is configured to energize the illumination source during an acceptable illumination condition. A method of facilitating operation of the flexible feeding tube with an imaging assembly including an imaging device and an illumination source and a controller is also disclosed. The imaging assembly is configured to generate imaging signals indicative of images of an alimentary canal of a subject. The illumination source is configured to illuminate an ambient environment of the imaging assembly. The controller is configured to receive the imaging signals and control the illumination source during an acceptable illumination condition. The method involves energizing the illumination source when an acceptable illumination condition is present and de-energizing the illumination source when the acceptable illumination condition is not present.2015-12-03
20150342837Vomit Collection Assembly - A vomit collection assembly for collecting vomit from an infant after the infant is burped includes a cup that collects vomit from the infant. A strap is coupled to the cup. The strap may insertably receive a user's hand. The cup is retained proximate the infant's mouth.2015-12-03
20150342838DENTAL COMPOSITION CONTAINING ION SUSTAINED-RELEASE GLASS - To provide a dental composition wherein the acid buffering capacity can be attained and the acid resistance of the tooth substance can be improved while maintaining very high foul breath inhibition capacity. A dental composition including: ion sustained-release glass; and a carrier for supporting the ion sustained-release glass, wherein the ion sustained-release glass is fluoroaluminoborosilicate glass having a composition range of: 15% to 35% by mass SiO2015-12-03
20150342839COMPOSITIONS AND METHODS FOR WHITENING TEETH - Compositions and methods for whitening the teeth of a patient or subject are described for performing a dental prophylaxis or cleaning procedure during which at least one tooth whitening composition is applied to the surface of a stained tooth, said compositions and methods resulting in a tooth color change that is noticeable to the patient or subject immediately following the procedure. The novel procedure allows for a high degree of tooth whitening to be safely achieved in a short period of time while under the control of a dentist, dental hygienist, or other dental professional, and which at least partially coincides with the performance of a dental prophylaxis or cleaning procedure in order to save significant clinical operatory chair time compared to cleaning and whitening procedures that are performed in non-overlapping time frames or appointments. Light may also be used to enhance whitening.2015-12-03
20150342840ION SUSTAINED-RELEASE DENTAL RESIN TEMPORARY SEALING MATERIAL COMPOSITION - A dental resin temporary sealing material composition that is excellent in adhesion to the tooth substance and removability of the hardened material and has a preventive function of releasing various ions including a fluoride ion is provided. The adhesion to cavity walls can be improved and, since there is little dimensional change during hardening, excellent sealability in a cavity can be attained.2015-12-03
20150342841POLYSILOXANE COMPOUND AND DENTAL MATERIALS THAT CAN BE PREPARED FROM IT - The invention relates to a polysiloxane compound comprising specific siloxane units, curable dental materials comprising one or more than one polysiloxane compound according to the invention, cured dental materials obtainable from the curable dental materials according to the invention, a method for preparation of polysiloxane compounds according to the invention, a method for preparing curable polysiloxane compounds according to the invention and a method for preparing cured dental materials according to the invention.2015-12-03
20150342842PROCESS OF FORMING CRYSTALS FOR USE IN A PERSONAL CARE COMPOSITION - A method of making a stable detersive surfactant containing personal care composition comprising the steps of emulsifying a stabilizing agent in the presence of anionic surfactant to form an emulsion containing droplets having a particle size of from about 0.1 to about 10 um. These particles are then cooled to form a stabilizing premix at a rate of about 10 to about 1000 C/min to form crystals from the droplets, the crystals having a maximum dimension of about 0.1 to about 3 um. These crystals are then added to a detersive surfactant containing personal care composition to increase stability.2015-12-03
20150342843TOPICAL LIPOSOME COMPOSITIONS CONTAINING PHENOLIC ANTI-INFLAMMATORY AGENTS AND THEIR METHODS OF PREPARATION - Liposomal topical compositions containing phenolic anti-inflammatory agents, and methods for making thereof, are presented. These compositions are generally used for helping to prevent solar radiation-induced skin damage and helping to prevent and/or treat inflammatory dry skin conditions caused by eczema and contact dermatitis.2015-12-03
20150342844FLUORIDE VARNISH - A tooth varnish that is free from pinus extracts, free of substantial undesired coloring agents, with a reduced viscosity, delivered in a user-friendly, flow-through, unit dose applicator and having improved fluoride release, uptake, and remineralization properties.2015-12-03
20150342845COSMETIC COMPOSITIONS WITH ENHANCED COLOR RETENTION FOR IMPROVED SKIN APPEARANCE - A cosmetic composition with enhanced water resistance, color intensity and color retention after exposure to water is disclosed herein. The composition comprises a water dispersible film former component, a skin adhesion promoter component, a color enhancer component, and one or more colorants. The synergy of the components contributes to the improved attributes of the composition.2015-12-03
20150342846Hair Styling Composition - The present application relates to a hair styling composition for use in permanently or semi-permanently styling hair, the composition comprising citronellyl methylcrotonate and hydrogen peroxide. The present application also concerns a related hair-styling kit for use in permanently or semi-permanently styling hair as well as associated uses and methods.2015-12-03
20150342847NOVEL DERIVATIVES OF SINAPINIC ACID AND THE COSMETIC OR PHARMACEUTICAL USES THEREOF - The present invention relates to a compound of general formula (I) below:2015-12-03
20150342848ANTIMICROBIAL COMPOSITIONS - An anti-microbial composition, comprising a chelator (such as EDTA and its salts), and a transport enhancer (such as Methyl Sufonyl Methane; MSM) is provided. Together, the combination of the two substances unexpectedly and beneficially inhibits bacterial or fungal biofilms when administered to an area of microbial infection. Preferred formulations include spray, lotion, solution, gel, cream, ointment, soap, deodorant, surgical rinse, or dental rinse.2015-12-03
20150342849SILICONE ELASTOMER PARTICLE AND AN AQUEOUS DISPERSION COMPRISING THE SAME - One of the purposes of the present invention is to provide a silicone elastomer particle and an aqueous dispersion of the silicone elastomer particles, which prevent generation of odor from oxygenation of nonionic surfactants. The present invention provides a silicone elastomer particle having a crosslinking structure formed by an addition reaction of a monovalent aliphatic unsaturated group bonded to a silicon atom and a hydrogen atom bonded to another silicon atom, wherein the silicone elastomer particle contains an antioxidant. Further, present invention provides an aqueous dispersion comprising the silicone elastomer particles, a nonionic surfactant and water.2015-12-03
20150342850HAIR CARE COMPOSITIONS AND METHODS OF USE - Hair care compositions including from about 0.005% to about 5% apigenin; from about 0.15% to about 12% of a solubilizing agent, wherein the solubilizing agent comprises an amine functional group; and at least about 20 weight percent of an aqueous carrier, where the composition has a pH ranging from about 3 to about 10, and methods of making the same are provided. These hair care compositions can be applied to any area of the scalp or hair where healthier hair appearance is desired.2015-12-03
20150342851TWO COMPONENT COMPOSITIONS CONTAINING ZINC AMINO ACID HALIDE COMPLEXES AND CYSTEINE - Provided are compositions, e.g., oral and personal care products, comprising (i) a zinc (amino acid or trialkyl glycine) halide complex, and (ii) cysteine in free or in orally or cosmetically acceptable salt form, together with methods of making and using the same.2015-12-03
20150342852COMPOUNDS USEFUL IN THE TREATMENT AND/OR CARE OF THE SKIN, HAIR AND/OR MUCOUS MEMBRANES AND THEIR COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Compounds of general formula (I): R2015-12-03
20150342853Topical Lightening Composition and Methods of Use Thereof - Embodiments of the invention are generally directed to compositions comprising glucose oxidase containing botanical extracts, and in particular extracts of 2015-12-03
20150342854EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME - The present invention has an object to provide an external dermal composition for anti-ageing, which prevents or improves apparent skin problems such as wrinkles, fine wrinkles, blemishes, and saggings caused by increasing age or ageing; and maintains or improves the barrier function and the hyaluronic acid production in the skin. The object is solved by providing an external dermal composition for anti-ageing, which contains an aqueous medium as a base material and one or more ingredients selected from L-ascorbic acid, derivatives thereof, and their salts as an effective ingredient(s).2015-12-03
20150342855COSMETIC COMPOSITION - Disclosed is a cosmetic composition comprising a first film-forming polymer having a contact angle of at least 85°, a second film-forming polymer having a contact angle of at least 85°, a lipid having a melting point of at least 5° C., optical particle, and at least 20% of water by weight of the composition.2015-12-03
20150342856Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations - Copolymers are described, containing a) 20.0-99.9% by weight of one or more structural units resulting from polymerizable substances of the following structural formula (I) in which R2015-12-03
20150342857COMPOSITIONS FOR STRAIGHTENING OR RELAXING HAIR - Disclosed herein is a composition for relaxing or straightening hair containing an alkaline material comprising hydroxide-containing compounds, a crosslinked copolymer of (meth)acrylic acid and/or (C1-C6)alkyl esters selected from a crosslinked (meth)acrylic acid/ethyl acrylate copolymer and a cross-linked anionic acrylate polymer, a cosmetically acceptable solvent, and optionally, thickening agents and surfactants. The compositions of the invention may be in the form of a gel that is clear in appearance or may be in the form of an emulsion when the compositions additionally contain a liquid fatty substance.2015-12-03
20150342858CARBOXYETHYL ACRYLATE CONTAINING COPOLYMER STABILIZER/THICKENERS AND METHODS TO MITIGATE THE LOSS OF SILICONE DEPOSITION ON KERATINOUS SUBSTRATES - A conditioning cleansing composition comprising at least one detersive surfactant, a silicone conditioning agent and a crosslinked acrylic copolymer stabilizer/thickener that mitigates the loss silicone deposition on keratinous substrates is disclosed. The crosslinked acrylic copolymer is prepared by polymerizing a monomer composition comprising: a) from about 5 to about 50 wt. % of carboxyethyl acrylate and/or oligomers thereof; b) from about 30 to about 95 wt. % of a monomer selected from ethyl acrylate, vinyl acetate, or mixtures thereof; c) from about 0 to about 50 wt. % of (meth)acrylic acid; and d) from about 0.001 to about 5 wt. % of a polyunsaturated crosslinking monomer containing at least two polymerizable ethylenically unsaturated moieties.2015-12-03
20150342859MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS - The invention relates to a molecularly imprinted polymer obtained by polymerization of a mixture comprising a basic ethylene monomer having an amine group, a crosslinking agent comprising at least 2 polymerizable ethylene unsaturations, a porogenic solvent and a C2015-12-03
20150342860IRRITATION MITIGATING POLYMERS AND USES THEREFOR - The present invention provides mild cleansing and cleaning compositions and methods for mitigating irritation induced by harsh detersive surfactants. The invention relates to a method of reducing skin irritation associated with a cleansing composition comprising at least one surfactant, the method comprising combining an effective amount of at least one nonionic amphiphilic polymer with at least one detersive surfactant selected from anionic surfactants, amphoteric surfactants, nonionic surfactants and combinations of two or more thereof. The at least one nonionic amphiphilic irritation mitigating polymer is prepared from a free radically polymerizable monomer composition comprising at least one hydrophilic monomer and at least one hydrophobic monomer, wherein said N-vinyl lactam and wherein said hydrophobic monomer is selected from a vinyl ester of a C2015-12-03
20150342861HAIR PRODUCT WITH STABLE VISCOSITY - A composition of matter, a hair product formulation, comprising three polymer species, one or more polyols, an emulsifier, and water. The formulation balanced between viscosity increasing components and viscosity decreasing components such that the viscosity is stabilized. The emulsifier being used to tune the viscosity of the solution.2015-12-03
20150342862USE OF ACRYLOYLDIMETHYLTAURATE SALT/VINYL PYRROLIDONE (VP) COPOLYMERS IN THE PREPARATION OF WET WIPES - The invention provides novel liquid compositions comprising acryloyldimethyltaurate salt/VP copolymer, as well as wet wipe products including such compositions.2015-12-03
20150342863NAIL COMPOSITIONS - The invention relates to nail composition sets comprising at least one primer comprising compound(s) other than acrylic latex and at least one color coat comprising at least one acrylic latex and water.2015-12-03
20150342864COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND AN ORGANOPOLYSILOXANE ELASTOMER - The subject of the present invention is a composition for topical application in the form of an oil-in-water or water-in-oil emulsion comprising at least one superabsorbent polymer and at least one organopolysiloxane elastomer. The subject of the invention is also the use of this composition in the cosmetics or dermatology field, and in particular for caring for, protecting and/or making up bodily or facial skin, or for haircare. The present invention makes it possible to obtain a composition which is soft on application, while at the same time providing comfort and moisturization, and stable over time. In particular, the present invention makes it possible to obtain an opalescent translucent gel which has a specific cosmeticity: stringy when taken up, with a significant “cushion” effect when massaging is begun (consistency and thickness under the finger on application) or even slightly dragging until the texture breaks under the fingers while at the same time keeping an application which ends with a certain glide.2015-12-03
20150342865COSMETIC COMPOSITION - Disclosed is a cosmetic composition comprising from 0.01 to 9% of film-forming polymer having a contact angle of at least 85° by weight of the composition, from 0.01 to 3.5% of fatty compound by weight of the composition and optical particle, wherein the fatty compound is selected from fatty acid, soap, or a mixture thereof.2015-12-03
20150342866Mild Hair Straightening Compositions - The present invention relates to a hair straightening composition comprising at least one emulsifying silicone elastomer, at least one naturally derived deposition polymer, at least one silicone conditioning agent, and an aqueous carrier.2015-12-03
20150342867Method For Straightening Hair Using Mild Hair Straightening Compositions - The present invention relates to a method for straightening hair comprising applying an effective amount of a hair straightening composition to hair, the composition comprising at least one emulsifying silicone elastomer, at least one naturally derived deposition polymer; at least one silicone conditioning agent, and an aqueous carrier, wherein said composition is not rinsed from the hair.2015-12-03
20150342868MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES - The invention relates to the use of molecularly imprinted polymer(s) or MIPs, of odorous molecule(s), as deodorant agent in particular for selectively trapping molecules that are the cause of human body odour. More particularly by using MIPs which may be obtained via polymerization of “sol-gel” type; it being understood that the polymerization is performed in the presence v) of one or more “templates” of target molecule(s) responsible for human body odour. Another subject of the invention concerns a NI process for preparing MIPs as defined previously, MIPs obtained via this process, and a cosmetic composition comprising at least one MIP as defined previously. Unexpectedly, it appears that the MIPs make it possible to specifically trap precursors of odorous molecules and odorous molecules that may be used in cosmetic formulations, especially those that are the cause of the unpleasant odour of sweat.2015-12-03
20150342869MOLECULARLY IMPRINTED POLYMERS OF SOL-GEL TYPE AND THEIR USE AS ANTIDANDRUFF AGENT - A subject matter of the invention is a molecularly imprinted polymer obtained by polymerization of a mixture comprising a silane, a tetra(C2015-12-03
20150342870Skin External Composition for Skin Moisturization Containing Red Yeast Rice Extract - Disclosed herein is a skin external composition containing a red yeast rice extract. More particularly, disclosed is a skin external composition containing a red yeast rice extract which can increase the production of loricrin in keratinocytes and to strengthen the skin barrier function, thereby exhibiting an excellent effect of improving skin moisturization.2015-12-03
20150342871HIGHLY PERMEATING TERBINAFINE FORMULATION - The present invention provides topical compositions, methods of preparation, and methods of treatment for onychomycosis. In certain specific embodiments, the invention provides an anti-fungal pharmaceutical composition for topical application comprising an anti-fungal agent, a zwitterionic surfactant or charged derivative thereof; a carboxylic acid, a lower alcohol, and water. The acid is selected from a short-chain hydroxy acid, a short-chain fatty acid, and a mixture thereof. In certain other specific embodiments, the invention provides an anti-fungal pharmaceutical composition for topical application comprising an anti-fungal agent, a quarternary amino acid, a keratolytic agent; a lower alcohol; and water. In certain embodiments, the keratolytic agent is urea, ammonium thioglycolate, or a mixture thereof.2015-12-03
20150342872Use of Paclitaxel Particles - A method of administering a suspension of paclitaxel particles into the peritoneum is provided. A corresponding method of treating a disease, disorder or condition that is therapeutically responsive to paclitaxel is also provided. The methods provide improvements over comparator formulations containing an equivalent dose of paclitaxel.2015-12-03
20150342873TRANSDERMAL DELIVERY OF BENEFICIAL SUBSTANCES EFFECTED BY A HOSTILE BIOPHYSICAL ENVIRONMENT - The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a hostile biophysical environment, beneficial substances may be delivered, according to certain embodiments, through the stratum corneum of the skin into the body. Beneficial substances include, but are not limited to, pharmaceutical agents, drugs, vitamins, co-factors, peptides, dietary supplements, and others. The beneficial effects disclosed include, for instance, relief of pain and inflammation, prevention and healing of ulcers of the skin, relief of headache, improved sexual function and enjoyment, growth of hair on the scalp, improving muscle size and/or function, removing body fat and/or cellulite, treating cancer, treating viral infections and others. A hostile biophysical environment may also be used in conjunction with systems and methods for increasing local blood flow, according to one set of embodiments. For example, by using a nitric oxide donor such as L-arginine, local blood flow may be increased, e.g., by transdermally delivering the nitric oxide precursor. The nitric oxide donor may be the sole cause of increased blood flow, or it may be supplemented with an adjunct such as theophylline.2015-12-03
20150342874Ophthalmic Formulations of Squalamine - The invention relates to ophthalmic formulations of squalamine or its pharmaceutically acceptable salts for the treatment of conditions of the eye such as, for example, wet age-related macular degeneration (wet AMD), choroidal neovascularization, retinopathy, dry age-related macular degeneration (dry AMD), polypoidal choroidal vasculopathy, neovascularization following ocular surgery, macular edema, retinal venous occlusion, subchoroidal neovascularization, retinal epithelial detachment, pterygum or foveal geographic atrophy of the retinal pigment epithelium.2015-12-03
20150342875IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME - Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.2015-12-03
20150342876METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OCULAR INFLAMMATORY DISEASES - The current invention provides a new and original method for treatment of ocular inflammatory diseases. More particularly, the present invention relates a mineralocorticoid receptor agonist for use in the treatment of an ocular inflammatory disease.2015-12-03
20150342877EXPANDABLE GASTRORETENTIVE DOSAGE FORM - An oral gastro-retentive delivery device is provided which unfolds rapidly upon contact with gastric juice. The device is configured in a collapsed configuration for oral intake and unfolding for gastric retention for a predetermined period of time and eventually reducing in size for passage through the rest of the GI track.2015-12-03
20150342878Particles for Inhalation Having Sustained Release Properties - The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent. Release of the agent from the administered particles occurs in a sustained fashion.2015-12-03
20150342879COMPOSITION OF DEXIBUPROFEN TRANSDERMAL HYDROGEL - Stable non-alcoholic transdermal hydrogel of dexibuprofen was prepared by using a simple manufacturing process, and the experimental trials showed that the pH modifying agent, antioxidant and water miscible solvent are the essential excipients to obtain stable non-alcoholic transdermal hydrogel of dexibuprofen. The dexibuprofen hydrogel prepared using carbopol as a gelling polymer produced an opaque gel, whereas hydrogel prepared using hyroxypropyl methylcellulose (HPMC) as a gelling polymer produced a transparent gel. There was no significant changes observed with respect to physical description, pH, assay and particularly to the related substance values when the hydrogels were subjected to the stability study at accelerated condition (40° C./75% RH) for 3 months in laminated tubes.2015-12-03
20150342880Solid Solution Compositions and Use in Chronic Inflammation - The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.2015-12-03
20150342881CURCUMIN SOLUBILISATE - A solubilisate composed of curcumin in a quantity of less than or equal to 10% by weight, preferably less than or equal to 7.5% by weight, particularly preferably 6% by weight, and at least one emulsifier having an HLB value in the range between 13 and 18, in particular polysorbate 80 or polysorbate 20 or a mixture of polysorbate 20 and polysorbate 80, wherein the average diameter of the micelles loaded with curcumin is between 5 nm and 40 nm, preferably between 6 nm and 20 nm, particularly preferably between 7 nm and 10 nm.2015-12-03
20150342882METHODS OF TREATMENT USING CADOTRIL COMPOSITIONS - Methods of treatment using cadotril compositions are disclosed.2015-12-03
20150342883Hyaluronidase and a Low Density Second PEG Layer on the Surface of Therapeutic-Encapsulated Nanoparticles to Enhance Nanoparticle Diffusion and Circulation - A delivery system comprising an organic nanoparticle, a hyaluronidase anchored or conjugated to the organic nanoparticle. The organic nanoparticle may be selected from a polymer-based nanoparticle, a lipid-based nanoparticle and nanoparticle formed by lipid-like molecules. In some embodiments, the hyaluronidase is covalently bound to a linker or spacer which, in turn, is anchored or covalently bound to the organic nanoparticle. The delivery system may also comprise an active pharmaceutical agent, a diagnostic agent, and/or a cellular membrane. The organic nanoparticle may further have a low density poly(ethylene glycol) layer on the surface. Methods for using the delivery system including for treating or diagnosing a disease are also provided. The organic nanoparticle provides enhanced diffusion/penetration through the extracellular matrix found in tumors, as well as increased circulation time in a human or animal body.2015-12-03
20150342884SOLID DOSAGE FORM COMPRISING MICRONIZED CYTISINE AND ITS PRODUCTION METHOD - The subject of the present invention is solid dosage form containing cytisine and ancillary substances characterised in that it contains from 0.1% to 5% micronised cytisine, wherein all molecules have a diameter less than from 10 μπι, corn starch from 40% to 60%, preferably 99.9% particles sized from 5 μπι to 25 μπι, macrocrystalline cellulose in an amount from 40% to 60%, preferably the particle size is: 99% below 38 μπι, wherein the mass ratio of ancillary substances to the active ingredient is from 1:19 to 1:999 and is in the form of a hard capsule as well as a method of obtaining it.2015-12-03
20150342885Ultra Low Density Pulmonary Powders - The invention provides pharmaceutical compositions for pulmonary delivery comprising particles containing a pharmaceutical agent and having a geometric size of greater than about 5 μm and a tap density of less than about 0.075 g/cm2015-12-03
20150342886PROCESS FOR PREPARING PRODUCTS COMPRISING STABILISED ACTIVES AND COMPOSITIONS COMPRISING SAME - The present invention broadly relates to a process for preparing products comprising active components, and in particular biological materials, wherein the active components are stabilised. The invention further relates to compositions comprising the products, and in particular compositions comprising therapeutic biological materials.2015-12-03
20150342887Production Of Inorganic-Organic Composite Materials By Reactive Spray-Drying - A composite material comprising at least one amorphous hydrophobic active ingredient in an amorphous salt matrix with a solubility in the neutral aqueous medium of less than 0.02 mol/l, obtained by a reactive spray-drying process, where a liquid phase A, which comprises inorganic cations, and a liquid phase B, which comprises anions which, with the inorganic cations, form a salt that is insoluble in the mixture of the liquid phases are sprayed together using at least one multi-substance nozzle, and where at least one hydrophobic active ingredient is present in dissolved form in at least one liquid spraying phase, and where the salt formed from the cations of phase A and the anions of phase B has a solubility of less than 0.02 mol/l in the neutral aqueous medium.2015-12-03
20150342888LYOPHILIZED FORMULATION COMPRISING GM-CSF NEUTRALIZING COMPOUND - The present invention relates to aqueous formulations comprising at least 20 mg/ml of a compound neutralizing GM-CSF, a lyoprotectant and an amino acid and/or a buffer. The ingredients of the formulation preferably provide stability to the compound neutralizing GM-CSF in view of lyophilisation, storage and reconstruction. In a preferred aspect, the formulation, e.g. after reconstruction, is for use in therapy, preferably for use in the treatment of inflammatory and autoimmune disorders, preferably including allergic and psoriatic disorders, as well as arthritic and asthmatic disorders. Furthermore, a kit comprising the formulation of the invention is provided.2015-12-03
20150342889TABLETS WITH IMPROVED ACCEPTANCE AND GOOD STORAGE STABILITY - The present invention relates to tablets for animals, having improved acceptance and good storage stability.2015-12-03
20150342890Dosator Apparatus for Filling a Capsule with Dry Powder - The present invention provides a dosator apparatus and methods for dispensing low density, high flowing powders into capsules at high target fill weights with accuracy and repeatability.2015-12-03
20150342891OSMOTIC DRYING OF ALL-AQUEOUS EMULSIONS - A one-step method for fabricating solidified particles from all-aqueous emulsion droplets involves solidification and drying of the droplets by osmosis. According to this method the fabrication of solidified particles is induced by implementing a high osmotic pressure gradient between the internal phase and external phase of the all-aqueous emulsion. The resultant extraction of water leads to solidification of the emulsion droplets. This approach provides mild conditions for encapsulating bioactive ingredients or other delicate components to conveniently fabricate bio- and cyto-compatible particles because it does not involve the introduction of external energy used in conventional drying. Such conventional external energy inputs are time-consuming, so the method is more efficient.2015-12-03
20150342892ENTERIC COATING FOR SOFT CAPSULE - The present disclosure relates to a novel aqueous coating composition comprising a polymer, at least one glidant, and at least one emulsifier, and at least one plasticizer, for soft capsule shells or softgel capsules, providing an enteric release profile, and to a method of enteric coating of soft capsule shells or containers; and to the resulting enteric coated soft capsule shells or softgel capsules with the aqueous coating composition.2015-12-03
20150342893CELECOXIB FORMULATIONS USEFUL FOR TREATING COLORECTAL CANCER - An oral celecoxib formulation, the formulation being a multiple minibead formulation wherein the minibeads comprise a hydrogel-forming polymer matrix in which are distributed celecoxib, a polyoxyethylated non-ionic surfactant and an anionic surfactant, the minibeads when combined with water being capable of releasing self-assembly structures comprising surfactant and celecoxib.2015-12-03
20150342894DRUG DELIVERY SYSTEMS AND RELATED METHODS OF USE - The present disclosure relates generally to drug delivery systems and related methods of use. The drug delivery systems can include one or more particles, each of which can include a biologically active compound dispersed therein. The drug delivery systems can also be configured to exhibit zero-order or near-zero-order release of the biologically active compound. The particles can be cylindrical or rod-like in shape, and can include a polymeric inner matrix having a biologically active compound dispersed therein, and a polymeric outer layer disposed at least partially around the inner matrix.2015-12-03
20150342895HYDROXYALKYL CELLULOSE - The present invention provides a hydroxyalkyl cellulose having a viscosity of 1.10 mPa·s to 1.95 mPa·s in a 2%-concentration aqueous solution at 20° C., and a solid formulation containing the hydroxyalkyl cellulose.2015-12-03
20150342896NANOPARTICLE FORMULATIONS FOR DELIVERING MULTIPLE THERAPEUTIC AGENTS - A formulation for treating a patient with hepatocellular carcinoma is disclosed. The formulation comprises therapeutic agents in the form of nanoparticles containing one or more proteins or polysaccharides. The therapeutic agent is conjugated to an active targeting agent causing the formulation to preferentially segregate to the hepatocellular carcinoma tissue to release the therapeutic agents. Methods of treating hepatocellular carcinoma using the formulations are also disclosed.2015-12-03
20150342897POLYPEPTIDE LOADED POCA NANOPARTICLES FOR ORAL ADMINISTRATION - Nanoparticles comprising biologically active peptides and poly(octylcyanoacrylate) as well as related subject matter is disclosed.2015-12-03
20150342898COMPOSITION AND FOOD OR DRINK - Compositions contain γ-oryzanol and biocompatible particles that incorporate γ-oryzanol inside thereof. The biocompatible particle may contain polylactideglycolide copolymer with a number mean particle size of 2.5 to 1,000 nm or a polyethylene glycol modification thereof. Such compositions are used for improvement of insulin resistance. In addition, such compositions are used for treatment or prevention of diseases selected from the group consisting of obesity, dystipidemia, impaired glucose tolerance, diabetes mellitus, arteriosclerosis, and inflammatory diseases.2015-12-03
20150342900Device for Delivery of Skin Care Composition - A novel device and method for delivering a liquid containing an active ingredient to a treatment site on the skin is disclosed. The device is useful for treating lesions or abnormal skin features such as corns, warts, calluses, bunions, actinic keratoses and hard hyperkeratotic skin as is often found on the face, arms, legs or feet.2015-12-03
20150342901COMPOSITION COMPRISING NATURAL POLYPHENOL COMPOUNDS, AND COMPOSITION FOR ORAL ADMINISTRATION COMPRISING SAME - Disclosed are a composition containing a natural polyphenolic compound and an orally ingestible composition including the composition containing a natural polyphenolic compound. The composition containing a natural polyphenolic compound may include a poorly water-soluble natural polyphenolic compound (PSNPPC) and saponin.2015-12-03
20150342902STABLE CANNABINOID FORMULATIONS - The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.2015-12-03
20150342903HYDROXYTYROSOL AND OLEUROPEIN COMPOSITIONS FOR INDUCTION OF DNA DAMAGE, CELL DEATH AND LSD1 INHIBITION - Compositions comprising hydroxytyrosol-containing formulations and treatment regiments comprising hydroxytyrosol and/or oleuropein and chemotherapeutic agents are disclosed. Compositions and/or regiments may optionally include the administration of vitamins, minerals, and anti-oxidants. Methods for using these compositions and treatment regimens for treating subjects for diseases, such as a malignancy, and for inducing or enhancing angiogenesis, treating or preventing oxidative stress, for treating or preventing high glucose-induced dysfunction, treating or preventing chemotherapy-induced dysfunction, and for improving cell viability are provided. Various methods for use of the hydroxytyrosol compositions for inhibition of lysine specific demethylase 1 (LSD1) in various cancers are also provided.2015-12-03
20150342904PHARMACEUTICAL COMPOSITION CONTAINING CURCUMIN - The subject matter of the invention is a pharmaceutical formulation which, according to the invention, contains curcumin or a curcumin derivative dissolved in an alcohol, an acid and an solubiliser. The formulation contains at most 12 percent by weight water and makes possible the production of an aqueous infusion solution, by means of which curcumin can be administered intravenously in dissolved form.2015-12-03
20150342905Methods for Overcoming Resistance to Tramadol - There is disclosed a method for treating disorders modulated by at least opiate receptor activity or monoamine activity, including acute and chronic pain, comprising administering a pharmaceutical formulation comprising O-desmethyltramadol. Methods are also provided that are effective for overcoming resistance to tramadol in patients.2015-12-03
20150342906Anti-sneeze and nose vestibule care - compositions, methods, and devices - Compositions, methods, and devices are herein disclosed for anti-sneeze and nose vestibule care for humans and other animals. An anti-sneeze composition includes an adrenergic agent, an anticholinergic agent, an antihistamine, a plasticizer for nose skin/nose muscle, and a soothing agent. A version of nose vestibule care composition includes alternative functional agents, such as anti-inflammatory agents, anti-oxidants, and antimicrobials, besides adrenergic, anticholinergic, and antihistamine agents. The alternative or additional agents are present in the invented composition for the purposes of wellness care of noses, prevention of diseases or aiding a medical treatment. The methods and devices for delivering the compositions to the nose vestibules for anti-sneeze, for wellness care, preventive care measure against diseases, and for aiding medical treatment of diseases are prescribed.2015-12-03
20150342907CINACALCET AND NEUROBLASTIC TUMOURS - The present invention relates to the field of pediatric or childhood tumor therapy. More specifically, the invention relates to the use of the allosteric activator of the calcium sensor receptor, cinacalcet, for the preparation of a pharmaceutical product for the treatment of neuroblastic tumors, particularly for the treatment of neuroblastomas, ganglioneuroblastomas and ganglioneuromas.2015-12-03
20150342908SECOAPORPHINE ALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEIN KINASE - The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably 1,10-dihydroxyaporphine. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.2015-12-03
Website © 2025 Advameg, Inc.